MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 17.02.2026
Accuray Incorporated Langfristige Verbindlichkeiten 2011-2026 | ARAY
Langfristige Verbindlichkeiten Jährlich Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 196 M | 161 M | 75.4 M | 199 M | 224 M | 212 M | 213 M | 95.1 M | 12.4 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 224 M | 12.4 M | 154 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
42.5 K | $ 2.19 | 3.79 % | $ 3.42 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 10.66 | 2.3 % | $ 1.44 B | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 12.79 | 1.51 % | $ 1.92 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 8.36 | -0.24 % | $ 600 M |  Israel |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 71.81 | 2.94 % | $ 106 B | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 36.75 | -1.76 % | $ 1.14 B | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.69 | 6.83 % | $ 37.6 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.12 | 3.91 % | $ 154 M |  France |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
Establishment Labs Holdings
ESTA
|
53.7 M | $ 64.8 | 2.08 % | $ 1.92 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 11.12 | 0.82 % | $ 301 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.43 | 0.08 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.22 | 1.37 % | $ 1.35 M | USA |
 |
InMode Ltd.
INMD
|
12.5 M | $ 13.58 | 1.08 % | $ 878 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.31 | -1.5 % | $ 21.1 M | USA |
 |
Abbott Laboratories
ABT
|
25.7 B | $ 111.67 | 1.56 % | $ 194 B | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 9.84 | 0.31 % | $ 352 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.35 B | $ 268.33 | 2.72 % | $ 7.57 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 9.19 | 2.0 % | $ 708 M | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 62.26 | 1.34 % | $ 3.4 B |  Britain |
 |
AxoGen
AXGN
|
1.61 M | $ 32.83 | -0.03 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
184 M | $ 176.49 | 4.15 % | $ 13.2 B | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 33.53 | 2.35 % | $ 5 K | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.77 | 2.72 % | $ 155 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.17 | 0.35 % | $ 403 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 86.71 | 3.14 % | $ 3.01 B | USA |
 |
MiMedx Group
MDXG
|
65.4 M | $ 4.46 | 1.02 % | $ 659 M | USA |